Home phase
 

Keywords :   


Tag: phase

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

2014-06-10 09:16:58| Biotech - Topix.net

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-DMPKRx.

Tags: type study treatment phase

 

MolMed TK Asco New Data from the Pivotal Phase III Randomized Trial TK008

2014-06-09 23:22:58| Logistics - Topix.net

Presented at ASCO data on the first set of patients from the pivotal Phase III TK008 study: the survival benefit exceeds trial target in acute leukaemia patients Milano June 9, 2014 - MolMed S.p.A. provided at the 50th ASCO annual meeting new data from the ongoing randomised pivotal Phase III study on its cell therapy product TK for high-risk acute ... (more)

Tags: data iii trial phase

 
 

Signal Sources And Phase Noise Test Systems

2014-06-09 20:24:08| rfglobalnet Home Page

There are many unique features specific to Berkeley Nucleonics’ microwave signal sources and phase noise test systems that give them an edge over their competition. At IMS 2014, Alex Palm spoke to us about what some of those features are and how they’re able to set themselves apart from their competitors. Check out the video to learn more. 

Tags: test systems sources phase

 

First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily Dosing Regimen of ISENTRESS (raltegravir)

2014-06-05 23:00:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. ONCEMRK Study Globally Enrolling Treatment-Nave Adults with HIV-1 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in the companys global Phase 3 clinical trial, ONCEMRK. ONCEMRK is assessing a once-daily investigational formulation of ISENTRESS (raltegravir), known as reformulated raltegravir, as part of combination HIV therapy for treatment-nave HIV-1-infected adults. Language: English Contact: MerckMedia Contacts:Caroline Lappetito, 267-305-7639Sarra Herzog, 908-423-6154orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of program trial phase

 

Dual Clock USB Synthesizer features low phase noise.

2014-06-05 14:31:02| Industrial Newsroom - All News for Today

Measuring 85 x 110 x 200 mm, Model SLC offers wideband coverage of 2 MHz to 7 GHz. Device combines multi-Digital Direct Synthesis with Phase Locked Loop to achieve low jitter measurements down to -170 dBc/Hz at 10 MHz. Supporting single and dual configurations in same housing, synthesizer provides up to 135 dB SNR for ADC/DAC testing. Typical applications include particle colliders, digital semiconductor testing, and network time synchronization. This story is related to the following:Phase Locked Synthesizers |

Tags: low features usb phase

 

Sites : [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] next »